Insider screener

Period: 12 months Type of trade: Sold × Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20,514 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20,514 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20,514 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20,514 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20,514 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20,514 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20,514 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
Daniel Gesua Sive Salvadori EVP and Group President
Sold at will
$102.29K 885 at 115.58
0.6%
Not planned
2 Mar 2026
Janet Liang President, Oscar Insurance
Sold on a plan
$99.80K 7,453 at 13.39
2.7%
Planned (10b5-1)
2 Mar 2026
Gina Mazzariello Chief Legal Officer
Sold at will
$99.38K 6,844 at 14.52
4.8%
Not planned
2 Mar 2026
Camille L Bedrosian Chief Medical Officer
Sold at will
$94.21K 6,461 at 14.58
3.7%
Not planned
2 Mar 2026
Douglas A. Linebarger Chief Legal Officer
Sold at will
$93.25K 5,518 at 16.90
2.5%
Not planned
2 Mar 2026
Larry Todd Edwards See Remarks
Sold on a plan 2×
$92.85K 3,687 at 25.18
2.1%
Planned (10b5-1)
2 Mar 2026
Erin Hagen SVP, CHRO
Sold at will
$90.93K 2,598 at 35.00
7.9%
Not planned
2 Mar 2026
Jessica Woelfel GC, CCO, and CS
Sold on a plan
$90.89K 869 at 104.59
13.0%
Planned (10b5-1)
2 Mar 2026
Regis T. Repko SVP, System Planning&Construct
Sold on a plan
$86.85K 663 at 131.00
9.3%
Planned (10b5-1)
2 Mar 2026
Jeannette Potts Chief Legal Officer
Sold at will
$85.35K 8,578 at 9.95
7.5%
Not planned
2 Mar 2026
Fernando M. Rodrigues President of BetterHelp
Sold on a plan
$83.48K 16,314 at 5.12
39.4%
Planned (10b5-1)
2 Mar 2026
Tsveta Milanova Chief Commercial Officer
Sold on a plan 2×
$83.06K 2,868 at 28.96
6.9%
Planned (10b5-1)
2 Mar 2026
Jean F Holloway SVP, General Counsel
Sold at will
$83.01K 2,183 at 38.02
1.3%
Not planned
2 Mar 2026
Dharmendra Kumar Sinha EVP, President, Public Cloud
Sold on a plan
$82.16K 45,393 at 1.81
1.8%
Planned (10b5-1)
2 Mar 2026
Eric Shroff Senior Vice President
Sold at will
$81.95K 709 at 115.58
1.8%
Not planned
2 Mar 2026
Alec Amar President
Sold on a plan
$78.65K 27,500 at 2.86
2.0%
Planned (10b5-1)
2 Mar 2026
Mary K Moreland Executive Vice President
Sold at will
$70.85K 613 at 115.58
0.6%
Not planned
2 Mar 2026
John A. McCoy Jr. Vice President and Controller
Sold at will
$67.61K 585 at 115.58
2.3%
Not planned
2 Mar 2026
Theodore James Washburn Jr. Principal Accounting Officer
Sold on a plan 3×
$64.38K 2,223 at 28.96
46.1%
Planned (10b5-1)
2 Mar 2026
Daniel S. Lorrain Chief Scientific Officer
Sold on a plan
$62.59K 4,170 at 15.01
2.7%
Planned (10b5-1)
2 Mar 2026
Victoria Baltrus Chief Accounting Officer
Sold on a plan
$62.10K 4,638 at 13.39
2.1%
Planned (10b5-1)
2 Mar 2026
Myriam Curet EVP & Chief Medical Officer · indirect
Sold on a plan
$61.57K 125 at 492.59
2.4%
Planned (10b5-1)
2 Mar 2026
David Joseph Gaffin EVP, CLO, Alkermes, Inc.
Sold on a plan
$59.58K 2,034 at 29.29
0.8%
Planned (10b5-1)
2 Mar 2026
Effie D Silva SVP, General Counsel & Secy
Sold at will
$58.53K 1,365 at 42.88
11.7%
Not planned
2 Mar 2026
Marshall S. Stanton SVP, Clinical & MD Affair
Sold at will
$57.53K 1,513 at 38.02
3.6%
Not planned
2 Mar 2026
Andrew Callos EVP, Chief Commercial Officer
Sold on a plan
$54.60K 886 at 61.62
1.7%
Planned (10b5-1)
2 Mar 2026
Tim Watkins CMO & Head of Development
Sold on a plan
$54.22K 3,611 at 15.02
100%
Sold half or more
2 Mar 2026
Ajay Ayyappan EVP & Gen Counsel/Corp. Sec'y.
Sold on a plan
$51.02K 1,679 at 30.39
3.0%
Planned (10b5-1)
2 Mar 2026
Dominic Smethurst Chief Medical Officer
Sold at will
$50.60K 6,097 at 8.30
6.4%
Not planned
2 Mar 2026
Nicholas Adam Jendusa Principal Accounting Officer
Sold at will
$48.55K 190 at 255.51
38.3%
Not planned
2 Mar 2026
Michael G. Nassy Sr EVP, Chief Credit Officer
Sold at will
$48.24K 3,100 at 15.56
5.3%
Not planned
2 Mar 2026
Stuart Poulton EVP, Chief Development Officer
Sold at will
$48.00K 5,101 at 9.41
5.1%
Not planned
2 Mar 2026
Reshma Rangwala EVP & Chief Medical Officer
Sold at will
$47.67K 5,066 at 9.41
8.2%
Not planned
2 Mar 2026
Uri Weinberg Chf Medical and Innovation Ofr
Sold at will
$43.61K 3,272 at 13.33
1.4%
Not planned
2 Mar 2026
Sohanya Roshan Cheng EVP & Chief Commercial Officer
Sold at will
$43.32K 4,604 at 9.41
4.1%
Not planned
2 Mar 2026
Seana Carson EVP, General Counsel
Sold on a plan
$39.63K 6,856 at 5.78
0.9%
Planned (10b5-1)
2 Mar 2026
Kellie Teal-Guess Chief Human Resources Officer
Sold on a plan
$38.49K 21,266 at 1.81
2.0%
Planned (10b5-1)
2 Mar 2026
Todd C. Skinner President, International
Sold on a plan
$38.32K 500 at 76.64
0.9%
Planned (10b5-1)
2 Mar 2026
Allison Swartz EVP, GC
Sold on a plan
$37.98K 2,199 at 17.27
2.2%
Planned (10b5-1)
2 Mar 2026
Jonathan L. Caldwell Chief People Officer
Sold on a plan
$37.35K 983 at 38.00
3.6%
Planned (10b5-1)
2 Mar 2026
Theodore Alan Huizenga SVP, Chief Accounting Officer
Sold at will
$37.21K 1,632 at 22.80
3.2%
Not planned
2 Mar 2026
Sarah Elizabeth Schubach Chief Accounting Officer
Sold on a plan
$35.04K 1,415 at 24.76
1.6%
Planned (10b5-1)
2 Mar 2026
Ashley Kavanaugh VP, Principal Accting Officer · indirect
Sold at will
$35.01K 836 at 41.88
48.5%
Not planned
2 Mar 2026
Michael Mano EVP, CLO&Secretary
Sold at will
$33.18K 3,526 at 9.41
3.6%
Not planned
2 Mar 2026
Russell Schundler General Counsel
Sold on a plan
$32.81K 1,073 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
Dean Richard Artis EVP & Chief Scientific Officer
Sold at will
$32.00K 5,894 at 5.43
3.2%
Not planned
2 Mar 2026
Jamie Dananberg Chief Medical Officer
Sold at will
$31.60K 5,820 at 5.43
4.5%
Not planned
2 Mar 2026
Robert Allen John Chief Revenue Officer
Sold on a plan
$31.33K 3,964 at 7.90
4.4%
Planned (10b5-1)
2 Mar 2026
Christopher Mutz Head of Rare Disease
Sold on a plan
$30.86K 417 at 74.00
0.4%
Planned (10b5-1)
2 Mar 2026
Elizabeth C. Cushman EVP, GC and Secretary
Sold at will
$30.40K 263 at 115.58
0.7%
Not planned
Showing 14,001–14,050 of 20,514. ← Newer Page 281 of 411 Older →